BriaCell Therapeutics Down 17% In US Premarket As Prices US$13.8 Million Public Offering
In This Article:
BriaCell Therapeutics (BCT.TO, BCTX) was down 17% at last look in US premarket trade after it overni
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.